However, in a case report, blockade of CTLA-4 with ipilimumab after progression of metastatic HNSCC on nivolumab monotherapy was shown to overcome treatment resistance and produced a long-lasting response (36). The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.